People

Anja Harmeier

roche.comnmdpharma.com

NMD Pharma nonexecutive director with neuroscience and rare-disease drug-development and venture-investing experience. The current issuer biography identifies her 2026 return to Roche Venture Fund as Head of Venture Investments, following Rewind and Pureos work. Holds a neuroscience/biochemistry doctorate from Freie Universität Berlin and an IE Madrid MBA. Roche’s current primary directory names Anja Harmeier as Head of Roche Venture Fund. NMD Pharma’s own biography states she returned as head in2026. The prior NMD and Mironid biography, original conference portrait and all company roles are preserved; no exact return date or personal check is inferred.